Skip to main content
. Author manuscript; available in PMC: 2021 Mar 1.
Published in final edited form as: Neurotoxicology. 2019 Dec 19;77:40–50. doi: 10.1016/j.neuro.2019.12.012

Table 2.

Brain monoamines and their metabolites in male C57BL6/J mice 6 h post chemicals exposure in Model 2 of Gulf War Illness.

Brain Region Monoamine or Metabolite Treatment
Vehicle –Vehicle Vehicle –LNFPIII PB/DEET/CORT/DFP –Vehicle PB/DEET/CORT/DFP-LNFPIII

PFC 5-HT 1.55 ± 0.38 4.91 ± 3.80 4.46 ± 3.10 1.47 ± 0.33
5-HIAA 2.64 ± 0.32 3.50 ± 0.62 2.52 ± 0.45 3.87 ± 0.95

DA 0.56 ± 0.22 0.45 ± 0.13 0.54 ± 0.14 0.58 ± 0.19
HVA 0.46 ± 0.12 1.35 ± 0.60 0.55 ± 0.15 1.50 ± 0.60

STR 5-HT 2.47 ± 0.50 2.63 ± 0.48 1.64 ± 0.34 2.64 ± 0.59
5-HIAA 2.64 ± 0.35 2.00 ± 0.58 2.81 ± 0..44 2.17 ± 0.75

DA 112.54 ± 8.75 105.11 ± 13.92 122.32 ± 6.93 102.28 ± 6.08
HVA 10.82 ± 1.40 9.26 ± 0.89 10.16 ± 1.16 11.73 ± 0.70

AMY 5-HT 3.84 ± 0.87 4.59 ± 0.71 4.72 ± 1.06 4.39 ± 1.46
5-HIAA 2.72 ± 0.64 2.86 ± 0.26 9.14 ± 3.57 3.42 ± 0.46

DA 12.87 ± 1.53 13.47 ± 3.54 13.63 ± 2.59 25.25 ± 6.76
HVA 4.10 ± 1.19 4.40 ± 2.06 3.27 ± 1.09 7.92 ± 2.35

dHip 5-HT 1.17 ± 0.39 0.97 ± 0.19 0.74 ± 0.23 1.02 ± 0.32
5-HIAA 3.41 ± 1.04 2.73 ± 0.49 5.66 ± 1.30 3.91 ± 1.04

DA 0.36 ± 0.12 0.27 ± 0.06 2.36 ± 1.84 a 0.84 ± 0.27 a
HVA 0.11 ± 0.02 0.27 ± 0.07 b 0.78 ± 0.15 a 1.45 ± 0.53ab

Data are presented as mean ± SEM; unit: ng/mg protein; n=6 per group, except the PB/DEET/CORT/DFP-Vehicle group, which was n=8).

a and b indicate significant main effect for GWI treatment (PB/DEET/CORT/DFP) or LNFPIII treatment, respectively, after a two-way ANOVA (p ≤ 0.05) and are bolded.

Italicized values indicate trend (p < 0.10) for main effect. Abbreviations: PFC: prefrontal cortex; NAc: nucleus accumbens; STR: striatum; AMY: amygdala; dHip: dorsal hippocampus; vHip: ventral hippocampus; 5-HT: serotonin; 5-HIAA: 5-hydroxyindoleacetic acid; DA: dopamine; HVA: homovanillic acid; PB: pyridostigmine bromide; DEET: N,N-Diethyl-methylbenzamide; DFP: diisopropylfluorophosphate; CORT: corticosterone; LNFPIII: lacto-N-fucopentaose III.